Mannitol Solution For Injection 10pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Mannitol: Solution for injection (10%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MANNITOL (MAN i tawl) is a diuretic. It is used to reduce pressure and swelling around the brain and in the eyes. It is also used to prevent or treat kidney failure. This medicine is also used during some urology procedures.

In-Depth Information
Select a Medication

Mannitol 10% Solution for Injection

NDC: 000747713
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Toxin Excretion Enhancement, Increased Intracranial Pressure, Cerebral Edema, Edema, Increased Intraocular Pressure, Oliguria

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Protect from freezing
Avoid excessive heat (above 104 degrees F)
Mannitol 10% Solution for Injection

Reported Side Effects for Mannitol 10% Solution for Injection

Blood Clot Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Brain Bruise Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Skin Necrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Osmotic Nephrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding In The Brain Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Retaining Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Heart Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: RAPID
Kidney Failure Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Irritated Blood Vessels Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: RAPID
High Potassium Level Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Blurred Vision Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Low Potassium Levels Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
High Sodium Levels Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: RAPID
Fluid In Lungs Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: EARLY
Abnormal Heart Rhythm Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
>6.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
>10.0%*
Severity: MILD
Onset: RAPID
Inceased Urination Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Mannitol

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5